Skin autofluorescence is associated with endothelial dysfunction in uremic subjects on hemodialysis

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Wang, Chun Cheng ^a,b,d   Wang, Yao Chang ^c   Wang, Guei Jane ^a,d,e   Shen, Ming Yi ^a   Chang, Yen Lin ^f   Liou, Show Yih ^g   Chen, Hung Chih ^d   Chang, Chiz Tzung ^d,h  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Buddhist Tzu Chi Medical Foundation   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^g Formosan Blood Purification Foundation   (Taiwan)

^h CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW MEASUREMENT; FLOW MEDIATED VASODILATION; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; SENSITIVITY AND SPECIFICITY; SKIN LEVEL; TISSUE LEVEL; UREMIA; VASODILATATION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RISK FACTOR; SKIN; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOMARKERS; CARDIOVASCULAR DISEASES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SKIN; VASODILATION;

EID: 84958211678     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147771     Document Type: Article

References (37)

1. Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, et al. Free levels of selected organic solutes and cardiovascular morbidity and mortality in hemodialysis patients: Results from retained organic solutes and clinical outcomes (ROSCO) investigators. PLoS One 2015;10(5):e0126048 doi: 10.1371/journal.pone.0126048 PMID: 25938230
2. U. S. Renal Data system, USRDS 2013 Annual Data Report: Atlas of chronic kidney disease and end stage renal disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland. 2015;4:2.
3. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-1615. PMID: 10405218
4. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the united states medicare population, 1998-1999. J Am Soc Nephrol 2005;16:489-495. PMID: 15590763
5. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538. PMID: 12371953
6. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-1160. PMID: 14522472
7. Miyazawa T, Nakagawa K, Shimasaki S, Nagai R. Lipid glycation and protein glycation in diabetes and atherosclerosis. Amino Acids 2012;42(4):1163-1170. doi: 10.1007/s00726-010-0772-3 PMID: 20957396
8. Weiss MF, Erhard P, Kader-Attia FA, Wu YC, Deoreo PB, Araki A, et al. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int 2000;57:2571-2585. PMID: 10844627
9. Miyata T, Saito A, Kurokawa K, de Strihou C V Y. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity. Nephrol Dial Transplant 2001;16(suppl4):8-11. PMID: 11402090
10. Sakata N, Noma A, Yamamoto Y, Okamoto K, Meng J, Takebayashi S, et al. Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease. Nephrol Dial Transplant 2003;18:1601-1609. PMID: 12897101
11. Brunet P, Gondouin B, Duval-Sabatier A, Dou L, Cerini C, Dignat-George F, et al. Does uremia cause vascular dysfunction? Kidney Blood Press Res 2011;34:284-290. doi: 10.1159/000327131 PMID: 21691132
12. Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC, et al. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens 2010;28:780-788. doi: 10.1097/HJH.0b013e328335043e PMID: 20186099
13. Raj D S C, Choudhury D, Welbourne TC, Levi M. Advanced glycation end products: A nephrologist's perspective. Am J Kidney Dis 2000;35(3):365-80. PMID: 10692262
14. Wagner Z, Molnár M, Molnár GA, Tamaskó M, Laczy B, Wagner L et al. Serum carboxymethyllysine predicts mortality in hemodialysis patients. Am J Kidney Dis 2006;47(2):294-300. PMID: 16431258
15. Schwedler SB, Metzger T, Schinzel R, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 2002;62:301-310. PMID: 12081592
16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S226. PMID: 11904577
17. Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, et al. Long-term association of brachial artery flow-mediated vasodilatation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 2009;134:52-58. doi: 10.1016/j.ijcard.2008.01.021 PMID: 18479768
18. Raitakari OT, Celermajer DS. Flow-mediated dilatation. Br J Clin Pharmacol 2000;50:397-404. PMID: 11069434
19. Iwamoto Y, Maruhashi T, Fujii Y, Idei N, Fujimura N, Mikami S, et al. Intimal-media thickness of brachial artery, vascular function, and cardiovascular riskfactors. Arterioscler Thromb Vasc Biol 2012;32:2295-2303. doi: 10.1161/ATVBAHA.112.249680 PMID: 22796580
20. Meerwaldt R, Graaff R, Oomen P H N, Links TP, Jager JJ, Alderson NL, et al. Simple non-invasive assessment of advanced glycation end product accumulation. Diabetologia 2004;47:1324-330. PMID: 15243705
21. de Vos LC, Noordzij MJ, Mulder DJ, Smit AJ, Lutgers HL, Dullaart RP, et al. Skin autofluorescence as a measure of advanced glycation end product deposition is elevated in peripheral artery disease. ArteriosclerThromb Vasc Biol 2013;33(1):131-138. doi: 10.1161/ATVBAHA.112.300016 PMID: 23139292
22. Teragawa H, Kato M, Kurokawa J, Yamagata T, Matsuura H, Chayama K. Usefulness of flow-mediated dilation of the brachial artery and/or the intimal-media thickness of the carotid artery in predicting coronary narrowing in patients suspected of having coronary artery disease. Am J Cardiol 2001;88(10):1147-1151. PMID: 11703961
23. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W, et al. skin collagen ancillary study group. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 1999;48(4):870-880.
24. Monnier VM, Sell DR, Genuth S. Glycation products as markers and predictors of the progression of diabetic complications. Ann N YAcadSci 2005;1043:567-581. PMID: 16037280
25. Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, Suzuki H, et al. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with type 2 diabetes. Diabet Med 2012;29:492-500. doi: 10.1111/j.1464-5491.2011.03448.x PMID: 21916970
26. Mulder DJ, van Haelst PL, Graaff R, Gans RO, Zijlstra F, Smit AJ. Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J 2009;17(4):162-168. PMID: 19421362
27. Mulder DJ, van Haelst PL, Gross S, de Leeuw K, Bijzet J, Graaff R, et al. Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis 2008;197(1):217-223. PMID: 17499742
28. Noordzij MJ, Lefrandt JD, Loeffen EA, Saleem BR, Meerwaldt R, Lutgers HL et al. Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease. Int J Cardiovasc Imaging 2012;28(2):431-438. doi: 10.1007/s10554-011-9805-6 PMID: 21336554
29. Ueno H, Koyama H, Tanaka S, Fukumoto S, Shinohara K, Shoji T, et al. Skin autofluorescence, marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 2008;57(10):1452-1457. doi: 10.1016/j.metabol.2008.05.016 PMID: 18803952
30. Kocak H, Gumuslu S, Sahin E, Ceken K, Gocmen YA, Yakupoglu G, et al. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients. Nephrology 2009;14:273-280. doi: 10.1111/j.1440-1797.2008.01062.x PMID: 19076287
31. Sönmez Uydeş-Doʇan B, Topal G, Takir S, Ilkay Alp F, Kaleli D, Ozdemir O. Relaxant effects of pravastatin, atorvastatin, and cerivastatin on isolated rat aortic rings. Life Sci 2005;76(15):1771-1786. PMID: 15698855
32. Deng HF, Xiong Y. Effect of pravastatin on impaired endothelium-dependent relaxation induced by lysophosphatidylcholine in rat aorta. Acta Pharmacol Sin 2005;26(1):92-98. PMID: 15659120
33. Nazratun N, Mahmood AA, Kuppusamy UR, Ahmad TS, Tan SY. Diabetes mellitus exacerbates advanced glycation end product accumulation in the veins of end-stage renal failure patients. Vasc Med 2006;11:245-250. PMID: 17390548
34. Zhou Y, Yu Z, Jia H, Sun F, Ma L, Guo R, et al. Association of serum pentosidine with arterial stiffness in hemodialysis patients. Artif Organs 2010;34(3):193-199. doi: 10.1111/j.1525-1594.2009.00801.x PMID: 20447043
35. Contreras I, Reiser KM, Martinez N, Giansante E, Lopez T, Suarez N, et al. Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM. Diabetes Care 1997;20(5):832-835. PMID: 9135951
36. Jadoul M, Ueda Y, Yasuda Y, Saito A, Robert A, Ishida N, et al. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of carbonyl stress. Kidney Int 1999;55:2487-2492. PMID: 10354298
37. Suliman ME, Heimbürger O, Bárány P, Anderstam B, Pecoits-Filho R, Rodríguez Ayala E, et al. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 2003;14(6):1614-1622. PMID: 12761263